- A slimming aid made from a southern African cactus (Hoodia) is set to be developed by UK firm Phytopharm and Unilever.
- Phytopharm will receive an initial fee of £6.5m from Unilever - out of a potential total of £21m - as well as future royalties on product sales.
- Production of the Hoodia cactus at Phytopharm's nursery in South Africa will rise from eight million plants to potentially hundreds of millions.
- Unilever will help the pharmaceutical firm develop snacks containing Hoodia extract.
- The firm had initially hoped to market a slimming drug from Hoodia with Pfizer.
